Bictegravir is a second-generation integrase inhibitor originally developed for HIV-1 infection. It is structurally related to dolutegravir and has been investigated as part of a single-tablet regimen with tenofovir alafenamide and emtricitabine.
İçerik kapsamı: Bu sayfadaki bilgiler kimyasal tanımlama ile endüstriyel tedarik, araştırma ve üretim bağlamlarına ilişkindir. Tedavi iddiası, tıbbi tavsiye veya ilaç kullanım talimatı niteliği taşımaz.
Bu bileşiği tedarik ediyor veya sağlıyor musunuz?
Envanterinizi listeleyin veya satın alma talebi gönderin
CAS 1644158-10-0
Methyl 5-((2,4-difluorobenzyl)carbamoyl)-1-(2,2-dimethoxyethyl)-3-methoxy-4-oxo-1,4-dihydropyridine-2-carboxylate
research compound
2-[(1R,5S,6S)-3-ethyl-6-(nitromethyl)-6-bicyclo[3.2.0]hept-3-enyl]acetic acid;phenylmethanamine
pharmaceutical intermediate
BENZYL TRANS-4-ETHOXY-2-(4-METHOXYCARBONYLPHENYL)PIPERIDINE-1-CARBOXYLATE
Pharmaceutical intermediate
Methyl 4-((2S,4S)-4-ethoxypiperidin-2-yl)benzoate
Pharmaceutical intermediate for drug synthesis
5-Bromo-2-hydroxy-4-methylpyridine
Pharmaceutical intermediate
(R)-2-(4-Hydroxy-6-methylnicotinamido)-2-(4-hydroxyphenyl)acetic acid
pharmaceutical intermediate
methyl 1-(2,2-dimethoxyethyl)-3-methoxy-4-oxo-5-[(2,4,6-trifluorophenyl)methylcarbamoyl]pyridine-2-carboxylate
RAIISLLLTMSJCR-UHFFFAOYSA-N
COC1=C(N(C=C(C1=O)C(=O)NCC2=C(C=C(C=C2F)F)F)CC(OC)OC)C(=O)OC
—